Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease

NCT00982072 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Minimal Change Disease

Interventions

DRUG: tacrolimus
DRUG: prednisolone

Sponsor

Imperial College Healthcare NHS Trust